Chembond Chemicals Ltd (CHEMBONDCH)
🎯 Key Takeaways
- Chembond Chemicals is transitioning from a mature chemical manufacturer to a growth-oriented player with strategic focus on diversifying beyond its dominant water treatment segment. Management is actively expanding its construction chemicals and distribution networks while pursuing geographic and product-led growth to reduce segment concentration and target ₹1,000 crore revenue in 4 years.
- Revenue declined 14.7% QoQ to ₹86 in Q1FY27.
- ⚠️ 1) Overreliance on water treatment (87% of revenue) exposes the company to sector-specific slowdowns or pricing pressures, particularly in public sect
- Market Cap
- ₹668
- P/E Ratio
- 17.5
- P/B Ratio
- 3.23
- ROE
- 18.5%
- ROCE
- 23.6%
- Debt/Equity
- 0.00
- Div Yield
- 0.50%
- Promoter
- 68.0%
📖 The Story
Chembond Chemicals is transitioning from a mature chemical manufacturer to a growth-oriented player with strategic focus on diversifying beyond its dominant water treatment segment. Management is actively expanding its construction chemicals and distribution networks while pursuing geographic and product-led growth to reduce segment concentration and target ₹1,000 crore revenue in 4 years. The company maintains a pristine balance sheet with zero debt and strong returns, but recent financial trends show margin compression and revenue volatility requiring execution discipline.
📰 What's Happening
Management has consistently highlighted execution of a multi-year growth strategy through product diversification and network expansion, particularly in construction chemicals and dealer networks across Maharashtra and Gujarat. The company achieved 36% growth in water technologies and 40% in distribution during H2, with 50% volume growth in water and 20% in construction chemicals. CAPEX of ₹21 crores was deployed on demerger effects and network expansion, supporting long-term revenue targets. Quarterly results show sequential revenue and profit fluctuations, but HY2 FY26 saw 35.6% revenue growth and 31% EBITDA growth driven by improved margins from lower input costs and new product technologies.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 73 | 86 | 101 | 86 |
| Operating Profit | 9 | 11 | 14 | 10 |
| OPM % | 12.8% | 12.8% | 14.2% | 11.7% |
| Net Profit | 7 | 10 | 12 | 10 |
| EPS | ₹2.69 | ₹3.62 | ₹4.36 | ₹3.54 |
Recent quarterly performance reveals revenue volatility — ₹86 crores in June 2026, up from ₹73 crores in September 2025 — but with improving profitability trends. OPM held steady around 12-14% despite inflationary pressures, supported by cost management and pricing power in private sector contracts. Net profit rose to ₹10 crores in June 2026 from ₹7 crores in September 2025, and EPS reached ₹3.54, indicating operational resilience. However, the sharp revenue dip in the latest quarter warrants monitoring of execution against the ₹326.15 crores FY26 revenue target and margin sustainability amid pricing pressures in public sector contracts.
🔮 Management Outlook & What's Next
Management projects FY26 revenue of ₹326.15 crores (+11.6% YoY) with EBITDA at ₹51.30 crores (+7% YoY), underpinned by growth across all business units and a strong order book. They aim to reduce water treatment's revenue share from 87% to 80-70% as other segments scale, signaling a deliberate shift toward diversification. CAPEX is being used for geographic expansion and new product commercialization to drive long-term growth, with no major strategic pivots announced but consistent emphasis on operational efficiency and margin protection through cost discipline.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|
| Equity Capital | 13 | 13 | 13 |
| Reserves | 161 | 194 | 171 |
| Borrowings | 0 | 0 | 0 |
| Total Liabilities | 216 | 254 | 218 |
| Fixed Assets | 21 | 23 | 20 |
| Investments | 35 | 31 | 43 |
| Total Assets | 216 | 254 | 218 |
The balance sheet remains exceptionally strong with zero net debt and growing equity and reserves — ₹194 crores in reserves as of March 2026, up from ₹161 crores a year earlier. Total assets have steadily increased to ₹254 crores, reflecting reinvestment of earnings rather than leverage. This financial flexibility supports ongoing CAPEX for network expansion and demerger-related initiatives without requiring external capital, aligning with a conservative capital allocation strategy focused on organic growth and shareholder returns.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2026 |
|---|---|
| Operating | +8 |
| Investing | +1 |
| Financing | -4 |
| Net Cash Flow | +5 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 67.7% | 67.9% | 68.0% | 68.0% |
| FII | 0.6% | 0.7% | 0.7% | 0.7% |
| DII | 0.8% | 2.0% | 2.1% | 2.6% |
| Public | 24.1% | 22.8% | 22.8% | 22.5% |
| # Shareholders | 12,364 | 11,777 | 11,344 | 10,732 |
Promoter holding has slightly increased to 68% in Q1FY27 from 67.74% in Q2FY26, indicating confidence in long-term prospects, while institutional interest remains minimal — FII ownership flat at ~0.65% and DII declining from 2.65% to 2.06% over the past year. The growing retail shareholder base (22.46% public) and rising number of shareholders (10,732) suggest improving market participation, but the lack of significant institutional accumulation may reflect limited visibility or sectoral investment preferences despite strong fundamentals.
⚖️ Peer Comparison — Chemicals
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| PIDILITIND | 1.53 L Cr | 57.6 | 33.4% | — | 0.01 |
| SRF | 72,171 | 33.4 | 15.6% | — | 0.36 |
| LINDEINDIA | 52,799 | 96.6 | 17.5% | — | 0.00 |
| FLUOROCHEM | 48,774 | 79.7 | 9.6% | — | 0.34 |
| NAVINFLUOR | 43,256 | 54.7 | 22.2% | — | 0.31 |
| GODREJIND | 35,513 | 30.2 | 9.2% | — | 4.57 |
| HSCL | 33,807 | 42.0 | 20.7% | — | 0.16 |
| AETHER | 23,029 | 97.7 | 13.8% | — | 0.08 |
| DEEPAKNTR | 20,783 | 26.5 | 15.3% | — | 0.26 |
| CASTROLIND | 19,792 | 18.6 | 76.2% | — | 0.00 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1) Overreliance on water treatment (87% of revenue) exposes the company to sector-specific slowdowns or pricing pressures, particularly in public sector contracts with fixed pricing. 2) Margin compression in recent quarters, despite cost controls, raises concerns about sustainability amid inflation and competitive pressures in construction chemicals. 3) Revenue volatility across quarters — including a sharp decline to ₹86 crores in June 2026 — may signal execution risks in scaling new segments or managing order book momentum.
📋 Recent Filings
- Announcement2026-09-28Chembond Chemicals has closed its insider trading window effective October 1, 2026, ahead of its upcoming unaudited financial results for the quarter …
- 🟡 Board Meeting2026-07-16Chembond Chemicals announced the outcome of its July 16, 2026 board meeting, approving unaudited standalone and consolidated financial results for the…
- Financial Results2026-06-26Chembond Chemicals Limited announced that its trading window will close on July 1, 2026, and remain closed until 48 hours after the unaudited financia…
- 🔴 Financial Results2026-05-27Chembond Chemicals reported consolidated revenue of Rs 326.15 crores for FY2026, up 12% YoY, driven by 36% growth in water technologies and 40% in dis…
- 🟡 Board Meeting2026-05-16Chembond Chemicals reported consolidated revenue of ₹187.7 crores for HY2 2025-26, up 35.6% from HY1, driven by 36% growth in Water Technologies and 1…
- 🔴 Financial Results2026-05-16Chembond Chemicals announced that the audio/video recording of its May 16, 2026 investor meet discussing audited financial results for the quarter and…
- 🟡 Board Meeting2026-05-16Chembond Chemicals Limited announced the Board's approval of audited standalone and consolidated financial results for the quarter and year ended Marc…
- 🔴 Financial Results2026-05-16Chembond Chemicals reported approved audited standalone and consolidated financial results for the quarter and fiscal year ended March 31, 2026, along…
- 🔴 Corporate Action2026-05-16Chembond Chemicals announced its 3rd Annual General Meeting on July 31, 2026, where shareholders will vote on a proposed dividend of Rs. 1.25 per shar…
- 🔴 Financial Results2026-05-13Chembond Chemicals announced its H2 FY2026 earnings call scheduled for May 16, 2026 at 15:00 IST to discuss audited financial results for the quarter …
🧠 Analyst's Read
Chembond Chemicals presents a stable, debt-free business with strong returns and management focus on strategic diversification, but near-term execution against growth targets and margin preservation will be critical. Investors should monitor quarterly order book trends, segment-wise margin performance, and progress toward reducing water treatment's revenue concentration as key indicators of strategic momentum.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-30.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when CHEMBONDCH files new disclosures
Track CHEMBONDCH filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track CHEMBONDCH — FreeFree account · 2 AI queries/day